Description
Technical & Manufacturing Relevance:
Widely used as a clinically positioned phytotherapeutic active for female hormonal balance, menstrual cycle regulation, PMS, mastalgia, luteal phase support, and menopausal wellness.
Acts primarily via dopaminergic modulation of prolactin secretion, making standardization critical for reproducible efficacy.
Standardized extracts (commonly 0.5%–1.0% agnuside or casticin-based markers) preferred for international nutraceutical and phytopharmaceutical markets.
Suitable for aqueous or hydroalcoholic extraction; compatible with spray drying, granulation, encapsulation, and tableting under GMP conditions.
Applicable Dosage Forms:
Tablets & capsules
Powders & granules
Liquid extracts, drops & tinctures
Sachets and stick packs
Combination women’s health formulations
Pharmacopoeial / Quality Notes:
Monographed in European Pharmacopoeia (Ph.Eur.) and recognized in USP–NF (dietary supplement monographs)
Typical quality parameters:
Assay: agnuside / casticin (HPLC)
Loss on drying: ≤8–10%
Residual solvents: as per ICH Q3C
Microbial limits, aflatoxins, heavy metals, and pesticide residues within international limits
Botanical authentication and chromatographic fingerprinting mandatory for export-grade supply.
Animal-Origin Declaration:
100% plant origin. No animal-derived ingredients. Suitable for vegetarian and vegan formulations.
Manufacturing Support:
Available for contract manufacturing, third-party manufacturing, private labeling, and white labeling of nutraceutical, phytopharmaceutical, and women’s health products.
Complete technical and regulatory documentation provided, including COA, MSDS, TDS, stability data, non-GMO statement, allergen declaration, clinical marker standardization reports, and export-compliant regulatory documents, enabling smooth resale and distribution in global markets.
